Site Search

Search
Showing 1 - 10 of 20 results
About the CF Foundation | Drug Pipeline | Antibiotics
FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade

CF Foundation's $1 Million Investment Helped Drug Known as Cayston® Become a Reality

Press Release |
| 4 min read
About the CF Foundation | Public Policy | Drug Pipeline
Statement from the Cystic Fibrosis Foundation on Senate HELP Committee’s Approval of the EXPERRT Act

Legislation Would Increase Patient and Expert Participation in FDA Review of Rare Disease Treatments

Press Release |
| 3 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Drug Pipeline
Cystic Fibrosis Foundation Therapeutics and Galapagos Initiate Alliance to Discover Drug Targets

Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement

Press Release |
| 4 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Drug Pipeline
Cystic Fibrosis Foundation Therapeutics and Alnylam Initiate Collaboration to Discover RNAi Therapeutic to Treat Cystic Fibrosis

Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts

Press Release |
| 5 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Drug Pipeline
Vertex Pharmaceuticals and Cystic Fibrosis Foundation Therapeutics Extend Collaboration for Cystic Fibrosis Drug Research
Press Release |
| 6 min read
About the CF Foundation | Drug Pipeline
GeneGo Rolls Out MetaMiner Cystic Fibrosis -- The First Disease-Specific Software Platform to Advance Drug Discovery
Press Release |
| 4 min read
About the CF Foundation | Cystic Fibrosis Foundation Therapeutics (CFFT) | Drug Pipeline
FoldRx Technology Enables Discovery of Novel Therapeutic Approach for Treating Cystic Fibrosis
Press Release |
| 5 min read
Research | CFTR Modulators | Drug Pipeline
Cystic Fibrosis Foundation statement on FDA approval of TRIKAFTA, the first triple combination therapy for the most common CF mutation

This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.  

Press Release |
| 3 min read
About the CF Foundation | Drug Pipeline | Our Research Approach
Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs

New Effort Will Search for Potential Therapies Targeting the Most Common Mutation of Cystic Fibrosis

Press Release |
| 4 min read